Hydrochloorthiazide and Hypernatriaemie

N/ACompletedNCT01974739

Frisius Medisch Centrum50 enrolled

Overview

Acquired hypernatremia appears to be associated with mortallity in ICU. To reduce hypernatremia and shorten the time of hypernatremia, we investigate the effect of hydrochloorthiazide compared to a placebo

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Hypernatraemia

Interventions

HydrochloorthiazideDRUG

placeboDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * sodium \> 142 Exclusion Criteria: * no informed consent

Locations (1)

Medical Centre Leeuwarden

Leeuwarden, Provincie Friesland, Netherlands

Outcomes

Primary Outcomes

sodium level

a decrease of 5 mmol/L sodium in plama

Time frame: 7 days

Secondary Outcomes

time hypernatraemia

decrease of duration high sodium level in plasma

Time frame: 7 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.